Pharmarise Holdings Corporation

2796・Standard Market・Retail Trade

Official website

Pharmarise Holdings Corporation

2796・Standard Market・Retail Trade

Official website

Pharmarise Holdings Corporation2796

Reference Indicators

Market Cap

59¥100M

P/E (Forecast)

—

P/B

0.9x

Dividend Yield (Forecast)

2.85%

ROE

1.7%

EV/EBITDA

5.6x

Financial Summary

Unit: ¥M

Item	2022May 2022	2023May 2023	2024May 2024	2025May 2025	2026May 2026
Net Sales	51,608	52,030	54,466	63,508	69,512
Cost of Sales	43,491	43,896	46,017	54,542	60,053
Gross Profit	8,117	8,134	8,449	8,965	9,459
SG&A Expenses	6,596	6,695	7,533	8,671	8,479
Operating Income	1,520	1,438	916	293	979
Non-operating Income	153	76	51	105	129
Non-operating Expenses	156	82	135	262	393
Ordinary Income	1,517	1,431	833	136	715
Extraordinary Income	23	137	63	165	108
Extraordinary Losses	218	518	752	293	125
Pre-tax Income	1,322	1,049	143	8	698
Income Taxes	864	702	485	390	591
Net Income	447	333	-351	-367	114
EBITDA	2,828	2,662	2,086	1,786	2,584
Gross Margin	15.7%	15.6%	15.5%	14.1%	13.6%
Operating Margin	2.9%	2.8%	1.7%	0.5%	1.4%
ROA	1.9%	1.4%	-1.2%	-1.1%	0.3%
ROE	7.2%	5.1%	-5.1%	-5.3%	1.7%

Segment Performance

Unit: ¥M

2025

Segment	Net Sales	Operating Income	Operating Margin
調剤薬局事業	52,625	578	1.1%
物販事業	8,696	-44	-0.5%
医学資料保管・管理事業	609	51	8.4%
医療モール経営事業	511	103	20.2%
その他	1,064	-52	-4.9%